Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Synergy Between PCI With TAXUS and Cardiac Surgery: SYNTAX Extended Survival

Trial Profile

Synergy Between PCI With TAXUS and Cardiac Surgery: SYNTAX Extended Survival

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Oct 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Coronary artery disease
  • Focus Therapeutic Use
  • Acronyms SYNTAXES
  • Most Recent Events

    • 29 Aug 2022 Results assessing the impact of bifurcation lesions on observed all-cause 10-year mortality , presented at the ESC Congress 2022 - Annual Congress of the European Society of Cardiology.
    • 18 Jul 2022 Results (n=1656) subgroup analysis rom this trial assessing effect of patient-reported preprocedural physical and mental health on 10-Year mortality after percutaneous or surgical coronary revascularization, published in the Circulation
    • 24 Mar 2022 Results (n = 1509) of post hoc analysis evaluating the long-term differences in survival between multiple arterial grafts and single arterial grafts in patients who underwent coronary artery bypass grafting,published in the European Journal of Cardio-Thoracic Surgery
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top